Modern ECT for Depression: Procedure, Benefits, Memory, and Safety

If your picture of ECT comes from a movie or a family story from decades ago, fear makes sense. Modern electroconvulsive therapy is still a serious medical treatment. It uses a controlled electrical stimulus to produce a seizure. It is also done under general anesthesia, with a muscle relaxant and constant medical monitoring. A fair explanation should include both facts.

ECT can be especially useful when depression is severe, psychotic, catatonic, life-threatening, or in need of a fast response. It also carries real anesthesia, medical, and memory risks. The decision deserves more than the label “last resort.”

Key takeaways

• Modern ECT is a planned medical procedure with anesthesia, muscle relaxation, physical monitoring, and a controlled therapeutic seizure.
• Electrode placement and pulse width change the balance between speed, benefit, and cognitive effects.
• Memory risk is real. Many test-measured effects improve after treatment, but pooled research finds a loss of personal memories that does not come back.

Zoom

What ECT is and what it is trying to do

Electrodes are placed on the scalp. A brief electrical stimulus triggers a seizure while the patient is unconscious and the body is relaxed by medication. Clinicians watch brain seizure activity, the heart, blood pressure, oxygen, and breathing. The goal is to change brain systems involved in a severe mood episode. The full mechanism is not settled.

ECT is not talk therapy, a punishment, or an uncontrolled procedure. General anesthesia is used so that the patient is unconscious during the stimulus, and the anesthesia team monitors how deeply the patient is sedated, specifically to guard against someone being too lightly sedated.1 The muscle relaxant greatly limits body movement. Neither fact means the rest of the day is free of headache, muscle soreness, nausea, fatigue, or confusion.

When clinicians consider it

ECT may be discussed for:

• severe major depression that has not improved enough with other treatment;
• depression with psychosis;
• catatonia;
• high suicide risk or another need for a faster response;
• inability to keep down food or fluids;
• a strong past response to ECT;
• severe depression during pregnancy when the individual risk-benefit review supports it;1
• a person who prefers ECT after an informed discussion of other reasonable options.

It does not have to wait until every medication has failed. CANMAT guidelines state that ECT can be used as a first-line treatment in severe illness, or for someone who responded well to ECT before. Severe illness includes a depressive episode with psychotic or catatonic features, severe suicidal thoughts, or a physical condition that is getting worse.2 Severity and time matter. A person who is dehydrated, psychotic, catatonic, or unable to stay safe faces a different decision from someone who is stable and comparing outpatient options.

A treatment morning, step by step

Details vary by service, hospital, health, and local rules. A typical visit includes:

1. Before arrival: the service gives medication, food, fluid, and transportation instructions. These are individualized. Do not change medicines or fasting on your own.
2. Preprocedure check: staff confirm identity, consent, recent health changes, medicines, fasting status, allergies, and the planned ECT technique. Pregnancy testing or other tests may be used when indicated.
3. Monitoring and IV: staff place an IV and attach heart, blood-pressure, oxygen, and brain-wave monitors. An anesthesia professional reassesses the patient.
4. Anesthesia: a short-acting anesthetic is given. A muscle relaxant follows. The team supports breathing and protects the teeth and mouth.
5. Electrode placement: electrodes are placed according to the planned right unilateral, bifrontal, or bitemporal technique.
6. Stimulus and seizure: the machine gives a measured electrical stimulus. The therapeutic seizure is monitored. Most last roughly 15 to 70 seconds, and the brain-wave seizure runs a little longer than the visible one.
7. Waking: the patient wakes in a recovery area. Staff check orientation, breathing, blood pressure, heart rhythm, pain, nausea, and other effects.
8. Observation and discharge: the patient stays until the team believes discharge is safe. A responsible adult usually provides transportation and supervision. Driving, alcohol, major decisions, work, and some activities are restricted for a period set by the service and anesthesia team. Guidelines note that the first month after a course is the period that most affects driving and big life decisions.1

The electrical part is brief. The full visit, recovery, and transportation plan take longer.

Technique changes the tradeoffs

Right unilateral ultrabrief ECT uses very short pulses, about 0.3 milliseconds, with both electrodes on the right side of the head. It usually carries the lightest short-term cognitive burden. It is also slightly less effective than brief-pulse treatment and tends to take about one more session. In a pooled analysis of six trials and 689 patients, the average course was 8.7 sessions with brief pulse and 9.6 sessions with ultrabrief, and the ultrabrief groups had a lower remission rate.3

Right unilateral brief-pulse ECT uses wider pulses, about 1 millisecond. When the stimulus dose is set high enough relative to a person’s own seizure threshold, it works well. A pooled analysis of seven trials and 792 patients found that high-dose right unilateral ECT did not differ from moderate-dose bitemporal ECT in antidepressant effect. Patients regained their orientation faster after each session and had less loss of personal memories at the end of the course.4

Bitemporal ECT places an electrode on each side of the head. Guidelines describe it as possibly more effective, and it is often chosen when speed matters most.2 It also causes more cognitive effects. The comparison above is the important caveat: once right unilateral treatment is dosed high enough, the efficacy gap largely closes.

Bifrontal ECT places electrodes across the front of the scalp. Evidence has not established it as better than the other placements overall. It does disturb heart rhythm less during the stimulus, so guidelines suggest considering it for patients at risk of ECT-induced heart rhythm problems.1

In a randomized trial of 90 adults, ultrabrief right unilateral ECT produced fewer cognitive effects than the other three tested combinations on virtually all of the primary cognitive measures.5 The results also showed why technique cannot be reduced to “gentle” versus “strong.” Stimulus dose, pulse width, electrode placement, and how the illness responds all interact.

The memory discussion should be direct

ECT can affect several kinds of thinking and memory:

• Immediate confusion: on waking, a person may not know the date or where they are. This usually clears, but the time varies.
• New learning: holding on to new information can be harder during a course and soon after it.
• Retrograde memory: memories formed before treatment may be harder to retrieve.
• Autobiographical memory: some people lose memories for personal events, often around the illness and treatment period. Some report broader or lasting gaps.

Many objective learning and memory tests improve after the acute period, especially as severe depression lifts.2 That does not justify promising full recovery. A 2025 systematic review and meta-analysis of nine studies, covering 432 patients and 173 comparison participants, found that people who had ECT lost more autobiographical memory than the comparison groups, with a standardized mean difference of 0.55. The effect was large after bitemporal ECT, at 0.82, and small after right unilateral ECT, at 0.32. Autobiographical memory did not return at long-term follow-up. The authors caution that the studies were mostly observational and generally small.6

A good service asks about memory before treatment, checks it during the course, listens to the patient and family, and is willing to change frequency or technique when risk starts to outweigh benefit. Guidelines list spacing treatments further apart, switching to unilateral placement, or shortening the pulse width as ways to lower the risk of lasting retrograde amnesia, while noting that these steps may reduce how well the treatment works.1 The patient should be told a tradeoff may be necessary, not reassured that the concern is imaginary.

Medical and anesthesia risk

During the seizure, heart rate and blood pressure can change. Anesthesia can affect breathing, heart rhythm, blood pressure, nausea, and recovery. Headache, jaw or muscle soreness, and fatigue can occur. Serious complications are uncommon in appropriately assessed patients, but “uncommon” is not the same as impossible.

The team reviews heart and lung disease, neurologic conditions, recent stroke or heart attack, anesthesia history, pregnancy, dental issues, and every medicine and substance. Some medicines change the seizure threshold, seizure length, blood pressure, bleeding, or recovery. Benzodiazepines and anticonvulsants can blunt the treatment, and lithium can raise the risk of confusion, so these are often adjusted or held.2 The review is not a fixed list of tests for everyone. It is a patient-specific plan among psychiatry, anesthesia, medicine, and other specialists when needed.

What an acute course looks like

An acute course usually uses two or three treatments a week. Six to twelve sessions is a common range, and response outcomes do not differ between twice-weekly and three-times-weekly schedules.2 Some people need fewer or more. Improvement is measured in symptoms, safety, nutrition, movement, thinking, and daily function. The team may change pulse width, electrode placement, stimulus dose, or frequency if response is too slow or cognitive effects are too high.

One successful treatment is not the full course. One acute course is also not a permanent shield against relapse. RANZCP guidelines report relapse rates above 50 percent within 12 months, with most relapses in the first six months, even when maintenance medication or maintenance ECT is used.1

What happens after response

A continuation plan may include medication, psychotherapy, less frequent continuation ECT, or a combination. Later maintenance ECT is considered for some people with repeated relapse or a strong prior response. Maintenance schedules typically range from weekly to once every three or four weeks, and a flexible schedule reviewed against how the person is doing tends to work better than a fixed one.1

The plan should be discussed before the acute course ends: what counts as response, who will manage medicines, how memory will be followed, which warning signs matter, and how fast treatment can restart if symptoms return.

ECT, TMS, esketamine, and IV ketamine

These are not raw efficacy rankings. The populations and outcomes differ. FDA device classification is also narrower than all clinical practice and should not be read as a personal recommendation.7 8 9

California consent: general information, not legal advice

California law requires a specific written informed-consent process before ECT. The explanation must cover the reason for treatment, the procedure and its probable frequency and duration, the improvement expected with and without it, the significant risks including the degree and duration of memory loss and whether it is irreversible, the reasonable alternatives and why this treatment is being recommended, and the fact that professional opinion is divided about how well it works.10 A patient who is able to consent may refuse, and may revoke consent for any reason at any time before or between treatments. A mental-health diagnosis by itself is not a reason to treat a confined person as unable to refuse. Added protections apply to involuntary patients and to minors, and California prohibits convulsive treatment under age 12. Ask your ECT service which rules apply to your exact setting, status, and age.

Questions to ask an ECT service

• Reason: Ask what problem the service is treating and why ECT is being considered now.
• Technique: Ask which electrode placement and pulse width the service recommends and what tradeoffs it expects.
• Medical review: Ask who will complete the anesthesia and medical review.
• Memory: Ask how the service will record your cognitive baseline and monitor memory during the course.
• Pace: Ask how often treatments will occur and what signs would make the service slow, pause, or change technique.
• Restrictions: Ask which transportation, supervision, driving, work, and decision restrictions apply.
• Endpoint: Ask how the team will decide that the acute course is complete.
• Aftercare: Ask what medication, therapy, continuation ECT, or maintenance plan follows response.
• Consent: Ask what happens if you say no now or withdraw consent between treatments.

When to get help sooner

Urgent evaluation is needed for suicidal intent, inability to stay safe, catatonia, psychosis, mania, severe agitation, inability to eat or drink, or rapidly worsening function. After ECT, follow the service’s emergency instructions for chest pain, trouble breathing, fainting, a prolonged or unexpected seizure, severe confusion that is not clearing, a new neurologic symptom, or another medical emergency.

If you may act on thoughts of suicide, or cannot stay safe, call or text 988 in the United States. Call 911 or go to the nearest emergency department for immediate danger.

What to do next

Ask for a consultation, not a commitment. Bring a support person if you want one. Request the proposed technique, expected benefits, memory risks, alternatives, consent rights, and maintenance plan in writing before deciding.

Frequently asked questions

Are you awake during ECT?

No. General anesthesia is used, and the anesthesia team monitors sedation depth during the procedure. Recovery can still include confusion, headache, nausea, fatigue, or muscle soreness.

Does ECT cause memory loss?

It can cause acute confusion, trouble learning new information, and loss of past or autobiographical memories. Many test-measured effects improve, but pooled research finds autobiographical memory loss that does not return, and it is larger after bitemporal than right unilateral treatment.

How many ECT treatments are typical?

Acute courses often involve two or three sessions weekly and commonly total 6 to 12, but the range and technique are individualized.

Is ECT only a last resort?

No. Guidelines describe ECT as a possible first-line treatment in severe illness, including psychotic or catatonic depression, severe suicidal thoughts, a worsening physical condition, or a strong prior response.

Can a patient withdraw consent?

California law says a patient who is able to consent may refuse ECT and may revoke consent for any reason at any time before or between treatments. Added protections apply for involuntary patients and minors. Ask your service which rules apply to your setting, status, and age.

This article is for education, not personal medical advice. Do not start, stop, restart, or change a medication without the clinician who manages it. Every numeric, regulatory, and citation claim was verified against primary journal, federal, and labeling sources on September 7, 2026. Guidelines, drug labels, and public-health data change; confirm current status before acting on anything here.

Related reading on NP FADY

• How TMS works
• IV ketamine for depression
• Spravato, or esketamine, for depression
• When the First Two Don’t Work: A Map of What Comes Next in Treatment-Resistant Depression

References

1. Weiss A, Hussain S, Ng B, Sarma S, Tiller J, Waite S, Loo C. “Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the administration of electroconvulsive therapy.” Australian & New Zealand Journal of Psychiatry. 2019. DOI: 10.1177/0004867419839139. Guideline page (listing last updated April 2019; link checked September 2026). Source for anesthesia depth and awareness monitoring, ECT in pregnancy, the bifrontal and cardiac-arrhythmia point, cognitive baseline and course monitoring, the driving and major-decision caution, relapse rates after an acute course, and maintenance ECT frequency.

2. Lam RW, et al. “Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 update on clinical guidelines for management of major depressive disorder in adults.” Canadian Journal of Psychiatry. 2024;69(9):641–687. DOI: 10.1177/07067437241245384. Open full text. Source for the first-line-in-severe-illness statement, the 6-to-12-session range and twice-versus-thrice-weekly equivalence, the placement and pulse-width tradeoffs, concomitant medication handling, and the recovery of objective cognitive testing after the acute period.

3. Tor PC, Bautovich A, Wang MJ, Martin D, Harvey SB, Loo C. “A systematic review and meta-analysis of brief versus ultrabrief right unilateral electroconvulsive therapy for depression.” Journal of Clinical Psychiatry. 2015;76(9):e1092-e1098. DOI: 10.4088/JCP.14r09145. PubMed.

4. Kolshus E, Jelovac A, McLoughlin DM. “Bitemporal v. high-dose right unilateral electroconvulsive therapy for depression: a systematic review and meta-analysis of randomized controlled trials.” Psychological Medicine. 2017;47(3):518–530. DOI: 10.1017/S0033291716002737. PubMed.

5. Sackeim HA, Prudic J, Nobler MS, Fitzsimons L, Lisanby SH, Payne N, Berman RM, Brakemeier EL, Perera T, Devanand DP. “Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy.” Brain Stimulation. 2008;1(2):71–83. DOI: 10.1016/j.brs.2008.03.001. PubMed.

6. Porter RJ, et al. “Cognitive side-effects of electroconvulsive therapy: what are they, how to monitor them and what to tell patients.” BJPsych Open. 2020;6(3):e40. DOI: 10.1192/bjo.2020.17. Open full text. Mathiassen AB, Semkovska M, Lundsgaard CC, Gbyl K, Videbech P. “Autobiographical memory after electroconvulsive therapy: systematic review and meta-analysis.” British Journal of Psychiatry. 2026;228(3):263–273. First published online May 13, 2025. DOI: 10.1192/bjp.2025.2. PMID 40357797. Open full text.

7. U.S. Food and Drug Administration. “Neurological Devices; Reclassification of Electroconvulsive Therapy Devices.” Federal Register. 2018. Final order. Codified at 21 CFR 882.5940, checked September 2026.

8. SPRAVATO (esketamine) nasal spray prescribing information, Janssen Pharmaceuticals. Current label, checked September 2026. Monotherapy for adult treatment-resistant depression approved January 21, 2025.

9. Taylor JJ, Newberger NG, Stern AP, Phillips A, Feifel D, Betensky RA, Press DZ. “Seizure risk with repetitive TMS: survey results from over a half-million treatment sessions.” Brain Stimulation. 2021;14(4):965–973. DOI: 10.1016/j.brs.2021.05.012. PubMed.

10. California Welfare and Institutions Code sections 5325(f) and 5326.2 through 5326.85: 5326.2 (amended effective January 1, 2025), 5326.3, 5326.4, 5326.5, 5326.7, 5326.75, 5326.8, and 5326.85. Statute text checked September 2026.

If you or someone you know is in crisis

• Call 911 or go to your nearest emergency room for any life-threatening emergency.
• 988 Suicide & Crisis Lifeline — call or text 988, available 24/7. En español: marque 988 y oprima 2. Veterans: 988 and press 1, or text 838255.
• Crisis Text Line — text HOME to 741741.
• The Trevor Project (crisis support for LGBTQ+ young people) — call 1-866-488-7386, or text START to 678-678.
• National Sexual Assault Hotline (RAINN) — call 1-800-656-HOPE (4673) or text HOPE to 64673; free, confidential, 24/7. Online chat at RAINN.org/hotline.
• National Domestic Violence Hotline — call 1-800-799-SAFE (7233) or text START to 88788; 24/7, help in 200+ languages. Online chat at TheHotline.org. If your phone or computer may be monitored, calling from a safer device is an option.
• Riverside County — Inland SoCal Crisis Helpline 951-686-HELP (4357), 24/7 (Inland SoCal United Way / 211+, in partnership with RUHS-BH); Community Access, Referral, Evaluation and Support (CARES) Line 800-499-3008, 24/7.
• San Bernardino County — Access Unit (Behavioral Health Helpline) 888-743-1478, 24/7; Mobile Crisis/CCRT 800-398-0018 (24/7, all ages) or text 909-420-0560. Arrowhead Regional Medical Center (ARMC) has a dedicated walk-in adolescent psychiatric ER (ages 13–17).
• Children under 13 — call 911 for immediate danger, contact your county's mobile crisis team (they respond to all ages), or go to the nearest pediatric emergency room.
• California Peer-Run Warm Line (non-crisis — someone to talk to) — call or text 1-855-600-WARM (9276); daytime and evening hours, not a 24/7 line.
• NP Fady (non-emergency) — for routine scheduling or questions, call (909) 707-6261. This line is not monitored for emergencies.